Using psychedelics to treat psychiatric diseases has become less controversial as scientists continue to reveal their underlying mechanisms. In a new eNeuro paper, researchers led by Pavel Ortinski, from the University of Kentucky, used male rats to assess how psychedelic drugs target the claustrum, a brain region with many receptors that psychedelics interact with.
The researchers found that activating claustrum neurons targeting a cognitive area implicated in psychiatric diseases (the anterior cingulate cortex) under psychedelic drug exposure strengthened projections onto these claustrum neurons. This did not occur when activating the neurons in normal conditions.
Says Ortinski, "One idea is that the intensely memorable experience common during psychedelic 'trips' is critical for success in psychiatric treatment. Neurons are thought to encode memories by strengthening their connections with other neurons, so this pathway may be the mechanism through which psychedelics intensify memories." Ortinski hopes to continue exploring whether this mechanism contributes to the success of psychedelics in alleviating psychiatric disease symptoms.
